{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T05:17:27Z","timestamp":1734585447865,"version":"3.30.2"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":51,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["phiro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physics and Imaging in Radiation Oncology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.phro.2024.100681","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T04:38:01Z","timestamp":1732855081000},"page":"100681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Feasibility and potential clinical benefit of dose de-escalation in stereotactic ablative radiotherapy for lung cancer lesions with ground glass opacities"],"prefix":"10.1016","volume":"32","author":[{"given":"Carla","family":"Cases","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meritxell","family":"Moll\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Benegas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Ballestero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergi","family":"Serrano-Rueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Antelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carles","family":"Gom\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.phro.2024.100681_b0005","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijrobp.2010.08.056","article-title":"A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy","volume":"82","author":"Barriger","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.phro.2024.100681_b0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.radonc.2013.10.011","article-title":"Predictive parameters of symptomatic radiation pneumonitis following stereotactic or hypofractionated radiotherapy delivered using volumetric modulated arcs","volume":"109","author":"Bongers","year":"2013","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.phro.2024.100681_b0015","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/j.ijrobp.2012.01.018","article-title":"Dose-volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer","volume":"83","author":"Matsuo","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2024.100681_b0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.radonc.2020.12.015","article-title":"Clinical and dosimetric predictors of radiation pneumonitis in early-stage lung cancer treated with Stereotactic Ablative radiotherapy (SABR) - An analysis of UK's largest cohort of lung SABR patients","volume":"156","author":"Saha","year":"2021","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.phro.2024.100681_b0025","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.athoracsur.2020.04.094","article-title":"Management of Ground-Glass Opacities in the Lung Cancer Spectrum","volume":"110","author":"Zhang","year":"2020","journal-title":"Ann Thorac Surg"},{"issue":"12","key":"10.1016\/j.phro.2024.100681_b0030","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.jtho.2019.08.002","article-title":"Distinct Prognostic Factors in Patients with Stage I Non-Small Cell Lung Cancer with Radiologic Part-Solid or Solid Lesions","volume":"14","author":"Fu","year":"2019","journal-title":"J Thorac Oncol"},{"issue":"4","key":"10.1016\/j.phro.2024.100681_b0035","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jtho.2018.12.030","article-title":"Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype","volume":"14","author":"Ye","year":"2019","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.phro.2024.100681_b0040","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1378\/chest.11-2501","article-title":"Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan","volume":"143","author":"Chang","year":"2013","journal-title":"Chest"},{"issue":"13","key":"10.1016\/j.phro.2024.100681_b0045","doi-asserted-by":"crossref","first-page":"1052796","DOI":"10.3389\/fonc.2023.1052796","volume":"19","author":"Li","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.phro.2024.100681_b0050","doi-asserted-by":"crossref","unstructured":"National Lung Screening Trial Research Team; Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011 Aug 4;365(5):395-409. 10.1056\/NEJMoa1102873. Epub 2011 Jun 29. PMID: 21714641; PMCID: PMC4356534.","DOI":"10.1056\/NEJMoa1102873"},{"issue":"2","key":"10.1016\/j.phro.2024.100681_b0055","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","article-title":"International association for the study of lung cancer\/american thoracic society\/european respiratory society international multidisciplinary classification of lung adenocarcinoma","volume":"6","author":"Travis","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"3","key":"10.1016\/j.phro.2024.100681_b0060","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ijrobp.2020.03.005","article-title":"Correlating Dose Variables with Local Tumor Control in Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Modeling Study on 1500 Individual Treatments","volume":"107","author":"Klement","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.phro.2024.100681_b0065","doi-asserted-by":"crossref","first-page":"18010","DOI":"10.1038\/srep18010","article-title":"Radiobiological modeling analysis of the optimal fraction scheme in patients with peripheral non-small cell lung cancer undergoing stereotactic body radiotherapy","volume":"11","author":"Huang","year":"2015","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.phro.2024.100681_b0070","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ijrobp.2011.06.1971","article-title":"Predicting chest wall pain from lung stereotactic body radiotherapy for different fractionation schemes","volume":"83","author":"Woody","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.phro.2024.100681_b0075","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1016\/j.ijrobp.2011.04.034","article-title":"Which is the optimal biologically effective dose of stereotactic body radiotherapy for Stage I non-small-cell lung cancer? A meta-analysis","volume":"81","author":"Zhang","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2024.100681_b0080","doi-asserted-by":"crossref","unstructured":"Bradley JD, Hope A, El Naqa I, Apte A, Lindsay PE, Bosch W, et al. A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data. Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):985-92. 10.1016\/j.ijrobp.2007.04.077. Epub 2007 Aug 6. PMID: 17689035; PMCID: PMC2196217.","DOI":"10.1016\/j.ijrobp.2007.04.077"},{"key":"10.1016\/j.phro.2024.100681_b0085","unstructured":"Ladbury CJ, Sampath S. Lung stereotactic body radiation therapy using simultaneous integrated BED-escalation for peripherally located non-small cell lung cancer. J Radiosurg SBRT. 2022;8(3):181-187. PMID: 36861004; PMCID: PMC9970741."},{"issue":"3, Suppl","key":"10.1016\/j.phro.2024.100681_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2021.07.317","article-title":"Escalating Tumor Dose via Simultaneous Integrated Boost (SIB) Stereotactic Body Radiation Therapy (SBRT) for Large (> 5 cm) Lung Masses","volume":"111","author":"Kenamond","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2024.100681_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109552","article-title":"Biological equivalent dose is associated with radiological toxicity after lung stereotactic ablative radiation therapy","volume":"183","author":"Cases","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2024.100681_b0100","doi-asserted-by":"crossref","unstructured":"Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C, et al. Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial. J Clin Oncol. 2020 Sep 1;38(25):2830-2838. 10.1200\/JCO.20.00818. Epub 2020 Jun 2. PMID: 32484754; PMCID: PMC7460150.","DOI":"10.1200\/JCO.20.00818"},{"issue":"1","key":"10.1016\/j.phro.2024.100681_b0105","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jtcvs.2012.12.047","article-title":"Japan Clinical Oncology Group Lung Cancer Surgical Study Group. Radiographically determined noninvasive adenocarcinoma of the lung: survival outcomes of Japan Clinical Oncology Group 0201","volume":"146","author":"Asamura","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.phro.2024.100681_b0110","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.radonc.2013.10.012","article-title":"Correlation of dose computed using different algorithms with local control following stereotactic ablative radiotherapy (SABR)-based treatment of non-small-cell lung cancer","volume":"109","author":"Chetty","year":"2013","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.phro.2024.100681_b0115","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1120\/jacmp.v15i2.4662","article-title":"Performance of dose calculation algorithms from three generations in lung SBRT: comparison with full Monte Carlo-based dose distributions","volume":"15","author":"Ojala","year":"2014","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.phro.2024.100681_b0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejmp.2016.11.104","article-title":"Dose calculation algorithm accuracy for small fields in non-homogeneous media: The lung SBRT case","volume":"44","author":"Fogliata","year":"2017","journal-title":"Phys Med"},{"issue":"6","key":"10.1016\/j.phro.2024.100681_b0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/acm2.12446","article-title":"The dosimetric effect of electron density overrides in 3DCRT Lung SBRT for a range of lung tumor dimensions","volume":"19","author":"Healy","year":"2018","journal-title":"J Appl Clin Med Phys"},{"issue":"8","key":"10.1016\/j.phro.2024.100681_b0130","article-title":"On the validity of density overrides for VMAT lung SBRT planning","volume":"41","author":"Wiant","year":"2014","journal-title":"Med Phys"},{"issue":"1","key":"10.1016\/j.phro.2024.100681_b0135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.prro.2018.08.005","article-title":"ITV-Based Robust Optimization for VMAT Planning of Stereotactic Body Radiation Therapy of Lung Cancer","volume":"9","author":"Liang","year":"2019","journal-title":"Pract Radiat Oncol"},{"issue":"11","key":"10.1016\/j.phro.2024.100681_b0140","article-title":"Prognostic Impact of Radiological Consolidation Tumor Ratio in Clinical Stage IA Pulmonary Ground Glass Opacities","volume":"12","author":"Xi","year":"2021","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.phro.2024.100681_b0145","doi-asserted-by":"crossref","first-page":"7754","DOI":"10.1002\/mp.16019","article-title":"Testing of an enhanced leaf model for improved dose calculation in a commercial treatment planning system","volume":"49","author":"Van Esch","year":"2022","journal-title":"Med Phys"},{"issue":"15","key":"10.1016\/j.phro.2024.100681_b0150","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ab8cd5","article-title":"A novel procedure for determining the optimal MLC configuration parameters in treatment planning systems based on measurements with a Farmer chamber","volume":"65","author":"Saez","year":"2020","journal-title":"Phys Med Biol"},{"issue":"11","key":"10.1016\/j.phro.2024.100681_b0155","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1002\/mp.14485","article-title":"Acuros\u00ae dose verification of ultrasmall lung lesions with EBT-XD film in a homogeneous and heterogeneous anthropomorphic phantom setup","volume":"47","author":"\u00d6llers","year":"2020","journal-title":"Med Phys"},{"issue":"3","key":"10.1016\/j.phro.2024.100681_b0160","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.clon.2021.08.012","article-title":"A Comparison of Isotoxic Dose-escalated Radiotherapy in Lung Cancer with Moderate Deep Inspiration Breath Hold, Mid-ventilation and Internal Target Volume Techniques","volume":"34","author":"Bainbridge","year":"2022","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.phro.2024.100681_b0165","doi-asserted-by":"crossref","unstructured":"Liang X, Zhang C, Ye X. Overdiagnosis and overtreatment of ground-glass nodule-like lung cancer. Asia Pac J Clin Oncol. 2024 Jan 4. 10.1111\/ajco.14042. Epub ahead of print. PMID: 38178320.","DOI":"10.1111\/ajco.14042"}],"container-title":["Physics and Imaging in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631624001519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631624001519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T07:55:04Z","timestamp":1734508504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405631624001519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":33,"alternative-id":["S2405631624001519"],"URL":"https:\/\/doi.org\/10.1016\/j.phro.2024.100681","relation":{},"ISSN":["2405-6316"],"issn-type":[{"type":"print","value":"2405-6316"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility and potential clinical benefit of dose de-escalation in stereotactic ablative radiotherapy for lung cancer lesions with ground glass opacities","name":"articletitle","label":"Article Title"},{"value":"Physics and Imaging in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phro.2024.100681","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100681"}}